Characterization is key: how to evaluate mRNA therapeutic safety and efficacy
Before release into the clinic mRNA therapeutics need comprehensive characterization. In this eBlog we review key quality attributes of mRNA therapeutics.
miRNAs are key regulators of expression and translation, however identifying where and how they bind can be a challenge. In this eBlog we reveal how miR-eCLIP can be used to directly profile miRNA activity.
Monitoring translation dynamics at the gene level can be effectively achieved by employing ribosome profiling techniques, such as Eclipsebio’s eRibo Pro technology.